Naganathan Girish 4
4 · DEXCOM INC · Filed Nov 27, 2023
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Naganathan Girish
EVP Chief Technology Officer
Transactions
- Sale
Common Stock
2023-11-09$93.27/sh−2,725$254,161→ 47,725 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 42,363 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 23,587 of which were granted on November 8, 2022 and shall vest through November 8, 2026.